In 2023, hospital discharges for malignant neoplasm of the breast in Italy stood at approximately 57,000. Based on forecasts from 2024 onwards, a steady increase is observed, rising from 57.15 thousand discharges in 2024 to 57.65 thousand in 2028. This reflects a minimal year-on-year growth rate, which suggests stability with an essentially stagnating trend. Over a five-year period (2024-2028), the compound annual growth rate (CAGR) indicates a very modest average yearly growth, emphasizing slight, if any, increases in hospital discharges.
Future trends to watch for include potential impacts of advancements in early detection, treatment reforms, and healthcare policy changes on hospital discharge rates. Additionally, shifts in demographic factors such as aging populations and increasing incidence rates may influence future projections.
